100
Participants
Start Date
May 10, 2018
Primary Completion Date
March 27, 2024
Study Completion Date
March 27, 2024
In open-label phase: treatment with tofacitinib
Treatment with investigational drug
In double-blind phase: treatment with tofacitinib or placebo in 1:1 ratio
Treatment with investigational drug or placebo
Semmelweis Egyetem, Budapest
Enhancing Care Foundation, Durban
Panorama Medical Centre, Cape Town
Universitair Ziekenhuis Gent, Ghent
Hospital Metropolitano, San José
Cohen Children's Medical Center of New York, New Hyde Park
Cohen Children's Medical Center of New York, Lake Success
Istituto Giannina Gaslini Istituto Pediatrico di Ricovero e Cura a Carattere Scientifico, Genova
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan
Vinnytsia Regional Children's Clinical Hospital, Vinnytsia
Hospital Universitario La Paz, Madrid
Istanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital Department of Pediatric Rheumatology, Kadikoy / Istanbul
Clínica de Investigacion en Reumatologia y Obesidad, S.C., Guadalajara
Hospital Universitario y Politecnico La Fe, Valencia
St. Josef-Stift Sendenhorst, Sendenhorst
"Communal Institution Dnipropetrovsk Specialized Clinical Medical Center of Mother and Child n.a.", Dnipro
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey
Municipal non-Profit Enterprise, Ivano-Frankivsk
Centro de Alta Especialidad en Reumatologia e Investigacion del Potosi, S.C., San Luis Potosí City
"CNE of Lviv Regional Council Western Ukrainian Specialized Pediatric", Lviv
Phoenix Children's Hospital, Phoenix
Children's Hospital Los Angeles, Los Angeles
Universitaetsklinikum Erlangen, Erlangen
Beijing Children's Hospital, Capital Medical University/Rheumatology Department, Beijing
Sir Ganga Ram Hospital, Rajinder Nagar
"Federal State Budgetary Scientific Institution Scientific and Research Rheumatology", Moscow
Children's Hospital of Soochow University, Suzhou
The Children's Hospital Zhejiang University School of Medicine, Hangzhou
Nirmal Hospital Pvt Ltd, Surat
Children's Hospital of Chongqing Medical University, Chongqing
The Second Xiangya Hospital of Central South University, Changsha
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan
Clinic of FSBEI HE BSMU MoH RF, Ufa
Guangzhou Women and Children's Medical Center, Guangzhou
Chengdu Women's and Children's Central Hospital, Chengdu
Institute of Child Health, Kolkata
Institute of Post Graduate Medical Education and Research & SSKM Hospital, Kolkata
Xi'an Children's Hospital, Xi'an
Rambam Health Care Campus, Haifa
Meir Medical Center - Pediatric Clinic, Kfar Saba
Instituto CAICI SRL, Rosario
Centro Medico Privado de Reumatologia, San Miguel de Tucumán
Faculdade de Medicina da UNESP, Botucatu
UPECLIN Unidade de Pesquisa Clinica da Faculdade de Medicina da UNESP, Botucatu
SPDM - Associacao Paulista para o Desenvolvimento da Medicina, São Paulo
SPDM - Associacao Paulista para o Desenvolvimento da Medicina, São Paulo
Instituto da Crianca do Hospital das Clinicas da FMUSP, São Paulo
Alberta Children's Hospital/University of Calgary, Calgary
Research Institute of McGill University Health Center, Glen site, Montreal
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im prof dr hab med Eleonory Reicher, Warsaw
Hacettepe University Medical Faculty, Ankara
Lead Sponsor
Pfizer
INDUSTRY